Patents for A61P 19 - Drugs for skeletal disorders (81,981)
02/1998
02/26/1998WO1997049818A3 G-beta-gamma regulated phosphatidylinositol-3' kinase
02/26/1998CA2264284A1 Arylsulfonylamino hydroxamic acid derivatives
02/26/1998CA2264192A1 Secreted proteins and polynucleotides encoding them
02/26/1998CA2264064A1 Imidazole compounds, compositions and use
02/26/1998CA2263875A1 Secreted proteins and polynucleotides encoding them
02/25/1998EP0824530A1 Aryl glycinamide derivatives, methods of producing these substances and pharmaceutical compositions containing such compounds
02/25/1998CN1174078A Chinese medicine for ischemic necrosis of thighbone head
02/25/1998CN1174052A Use of cajanus cajan medicine
02/24/1998US5721240 9-substituted-8-unsubstituted-9-deazaguanines
02/24/1998US5721225 Skin disorders; osteoporosis
02/24/1998US5721224 Method of treating metabolic bone diseases with 18-nor-vitamin D compounds
02/24/1998US5720977 Oral water soluble pharmaceutical compositions containing estrone compound and calcium salt
02/24/1998US5720974 Compression molding mixture of active material, carbohydrate and water
02/21/1998CA2213361A1 Stable, long acting salts of carboxamides for the treatment of joint disease
02/19/1998WO1998006740A1 Dipeptide benzamidine as a kininogenase inhibitor
02/19/1998WO1998006733A1 Nucleotide sequence encoding the cd33-like protein
02/19/1998WO1998006711A1 Butyric acid matrix metalloproteinase inhibitors
02/19/1998WO1998006708A1 Crystalline form of 4-[5-methyl-3-phenylisoxazol-4-yl]benzenesulfonamide
02/19/1998WO1998006701A1 Il-8 receptor antagonists
02/19/1998WO1998006692A1 Novel immunotherapeutic agents and their use in the reduction of cytokine levels
02/19/1998WO1998006397A1 Il-8 receptor antagonists
02/19/1998WO1998006262A1 Il-8 receptor antagonists
02/19/1998DE19632772A1 Neue Benzamidine New benzamidines
02/19/1998CA2264104A1 Crystalline form of 4-[5-methyl-3-phenylisoxazol-4-yl]benzenesulfonamide
02/19/1998CA2263388A1 Il-8 receptor antagonists
02/19/1998CA2263344A1 Dipeptide benzamidine as a kininogenase inhibitor
02/18/1998EP0719148B1 Oral water soluble pharmaceutical compositions containing estrone derivative and calcium salt
02/18/1998CN1173497A Heterocycle-containing carbonic acid derivatives
02/18/1998CN1173364A 灵通打药酒及其制取方法 Well-informed wine and its preparation method of playing
02/18/1998CN1173359A Fast-acting antalgesic medical ointment series for external pain
02/18/1998CN1173344A Effective medicine composition for treatment of rheumatism and its capsule
02/18/1998CN1173341A Prescription for treatment of spur and its tech.
02/18/1998CN1173338A External application powder for removing numbness
02/17/1998US5719161 Alkoxy alkyl carbamates of imidazo(1.2-a)pyridines
02/17/1998US5719136 Combination of progesterone antagonists and antiestrogens with partial agonistic action for hormone substitution therapy for perimenopausal and postmenopausal women
02/12/1998WO1998005683A1 Parathyroid hormone analogues for the treatment of osteoporosis
02/12/1998WO1998005353A1 hCG AND DERIVATIVES AS MATRIX METALLOPROTEASES INHIBITORS
02/12/1998WO1998005336A1 Inhibitors of cysteine protease
02/12/1998WO1998005335A1 PURINE INHIBITORS OF CYCLIN DEPENDENT KINASE 2 AND IλB-$g(a)
02/12/1998WO1998005319A1 Methods of preventing skeletal problems in poultry
02/12/1998WO1998005318A1 Conjugated linoleic acid to maintain or enhance bone mineral content
02/11/1998EP0823478A2 Human cartilage gp 39-like gene
02/11/1998EP0822986A1 Antagonists of human interleukin-6 that are totally incapable of binding gp 130, and their use in the preparation of pharmaceutical compounds
02/11/1998EP0822832A1 Cd45rb binding compounds for the prevention of transplant rejection
02/11/1998CN1172801A Fluorinated vitamin D3 analogs
02/11/1998CN1172666A Medicine for treating osteoporosis and its preparing method
02/10/1998US5717062 Cyclic analogs of PTH and PTHrP
02/10/1998US5716955 Cytokine inhibitor
02/10/1998US5716942 Treatment of migraine with morpholine tachykinin receptor antagonists
02/05/1998WO1998004714A1 A NOVEL HUMAN mRNA EDITING ENZYME
02/05/1998WO1998004694A2 Secreted proteins and polynucleotides encoding them
02/05/1998WO1998004591A1 Novel parathyroid hormone-related peptide analogs
02/05/1998WO1998004527A1 Pyranoindole and carbazole inhibitors of cox-2
02/05/1998WO1998004287A1 The use of proteinase inhibitors for prevention or reduction of bone resorption
02/05/1998WO1998004276A1 Use in a composition of an extract of at least one labiate
02/05/1998WO1997047744A3 T-cell selective interleukin-4 agonists
02/05/1998WO1997038084A3 Polynucleotides derived from a pbmc cdna library encoding secreted proteins
02/05/1998CA2261588A1 Pyranoindole and carbazole inhibitors of cox-2
02/05/1998CA2261581A1 Secreted proteins and polynucleotides encoding them
02/05/1998CA2261567A1 The use of proteinase inhibitors for prevention or reduction of bone resorption
02/05/1998CA2260740A1 A novel human mrna editing enzyme
02/04/1998EP0822190A1 Phenyl heterocycles as cyclooxygenase-2 inhibitors
02/04/1998EP0821671A1 Arylsulfonyl hydroxamic acid derivatives as mmp and tnf inhibitors
02/04/1998EP0821668A1 Derivatives of succinamide and their use as metalloproteinase inhibitor
02/04/1998EP0821666A1 Derivatives of succinamide and their use as metalloproteinase inhibitors
02/04/1998CN1172483A Substituted heterocyclic compounds, preparation method thereof and pharmaceutical compositions containing same
02/04/1998CN1172435A Use of non-mammalian DNA virus to express exogenous gene in mammalian cell
02/04/1998CN1171959A Traditional Chinese medicine preparation for curing osteoproliferation disease and its preparing technology
02/03/1998US5714504 Alkaline salts of omeprazole; antiulcer agents; magnesium omeprazole or sodium omeprazole for example
01/1998
01/29/1998WO1998003670A1 Induction of t cell tolerance using a soluble molecule that can simultaneously block two costimulatory pathways
01/29/1998WO1998003511A1 New triazolopurines, method of preparing them and their use as drugs
01/29/1998WO1998003502A1 Substituted 2(2,6-dioxopiperidin-3-yl)phthalimides and -1-oxoisoindolines and method of reducing tnf-alpha levels
01/29/1998WO1998003484A1 Substituted pyridines as selective cyclooxygenase-2 inhibitors
01/29/1998DE19629378A1 Neue Triazolopurine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel Triazolopurine new, processes for their preparation and their use as medicaments
01/29/1998CA2260752A1 Induction of t cell tolerance using a soluble molecule that can simultaneously block two costimulatory pathways
01/29/1998CA2256736A1 New triazolopurines, method of preparing them and their use as drugs
01/28/1998EP0821004A1 Novel peptides and remedy for bone diseases containing the same as active ingredient
01/28/1998EP0820991A2 Cycloalkyl derivatives as bone resorption inhibitors and vitronectin receptor antagonists
01/28/1998EP0820988A2 Imino derivatives as bone resorption inhibitors and vitronectin receptor antagonists
01/28/1998EP0820290A1 Use of vitamin d 2 or vitamin d 4-derivatives for the manufacture of a medicament for the treatment of secondary hyperparathyroidism
01/28/1998CN1171395A Preparation of aromatic nitriles
01/28/1998CN1171246A Complete medicine zhuibikang' for treating protrusion of intervertebral disc and preparing process thereof
01/27/1998US5712300 Hydroxamic acid derivatives useful for the treatment of diseases related to connective tissue degradation
01/27/1998US5712294 Antiinflammatory agents
01/27/1998US5712291 Methods and compositions for inhibition of angiogenesis
01/27/1998US5712115 Polynucleotide encoding polypeptide with amino acid sequences
01/27/1998US5712104 Screening test for cancer, aids/hiv, influenza
01/24/1998CA2211148A1 Novel imino derivatives as inhibitors of bone resorption and vitronectin receptor antagonists
01/22/1998WO1998002436A1 Thiadioxobenzodiazepine inhibitors of farnesyl protein transferase
01/22/1998WO1998002151A2 Chemokine receptor antagonists and methods of use therefor
01/22/1998WO1998002144A1 Compositions containing at least one nucleic acid
01/22/1998CA2260284A1 Compositions containing at least one nucleic acid
01/22/1998CA2260216A1 Thiadioxobenzodiazepine inhibitors of farnesyl protein transferase
01/22/1998CA2259927A1 Chemokine receptor antagonists and methods of use therefor
01/21/1998EP0819436A2 Pharmaceutical and dietary composition containing sodium-, potassium-, magnesium- and calcium-ions and enzyme activators
01/21/1998CN1171119A Binding agents for curing inflammatory, autoimmune or allergic diseases
01/21/1998CN1170608A Preparing method for resetting lumbar intervertebral disc
01/20/1998US5710167 Hydroxamic acid derivatives with tricyclic substitution for treating degenerative joint diseases
01/20/1998US5710158 Inhibitors of protein tyrosine kinase and epidermal growth factor
01/20/1998US5710140 Phenyl heterocycles as COX-2 inhibitors